British journal of Cancer |
Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma |
juil. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
British journal of Cancer |
A randomised phase II study of second-line XELIRI regimen versus irinotecan monotherapy in advanced biliary tract cancer patients progressed on gemcitabine and cisplatin |
aoû. 18 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Prediabetes and diabetes in relation to risk of gastric adenocarcinoma |
juin. 19 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2) |
sep. 15 |
2 ♥ |
Cancers autres (hors CCR et CHC), Œsophage/Estomac |
British journal of Cancer |
A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer |
juin. 16 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity |
mai. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib |
oct. 17 |
3 ♥ |
Cancers autres |
British journal of Cancer |
Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study |
juil. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer |
juil. 18 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer |
juin. 16 |
|
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project |
juin. 17 |
2 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations Open |
oct. 17 |
2 ♥ |
Cancers autres |
British journal of Cancer |
Role of nutritional status and intervention in oesophageal cancer treated with definitive chemoradiotherapy: outcomes from SCOPE1 |
juil. 16 |
3 ♥ |
Cancers autres (hors CCR et CHC), Œsophage/Estomac |
British journal of Cancer |
Comparison of anal cancer screening strategies including standard anoscopy, anal cytology, and HPV genotyping in HIV-positive men who have sex with men |
aoû. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma |
Jan. 19 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma |
sep. 15 |
1 ♥ |
Carcinome hépatocellulaire (CHC), Foie |
British journal of Cancer |
Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach |
juin. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer |
nov. 17 |
3 ♥ |
Cancers autres |
British journal of Cancer |
Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer |
sep. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
Journal of the National Cancer Institute (JNCI) |
Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma |
mai. 15 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
Journal of the National Cancer Institute (JNCI) |
Analysis of Postoperative Recurrence in Stage I–III Midgut Neuroendocrine Tumors |
mar. 18 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial. |
sep. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Tumor-Infiltrating Lymphocytes, Crohn's-Like Lymphoid Reaction, and Survival From Colorectal Cancer |
mai. 16 |
2 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis |
nov. 18 |
1 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial |
aoû. 16 |
2 ♥ |
Cancer colorectal (CCR) |